Patients with asthma and allergic bronchopulmonary aspergillosis experienced improvements with dupilumab, according to data presented at the American Thoracic Society International Conference.Quality ...

ABPA is an exaggerated immune response that primarily occurs in individuals with asthma or cystic fibrosis. This form of aspergillosis is characterized by airway inflammation, mucus plugging, and ...

Have you noticed squishy floors? Developed mysterious health symptoms? Learn the red flags of a toxic mold problem in your house. How toxic is mold? Any mold that produces mycotoxins—the “myco” refers ...

One study calculated that 2.5% of adults who have asthma also have ABPA, which is approximately 4.8 million people worldwide. Of these 4.8 million people who have ABPA, an estimated 400,000 also ...

One study calculated that 2.5% of adults who have asthma also have ABPA, which is approximately 4.8 million people worldwide.

The cutoff value of IgE has been proposed as 1000 IU/ml pending further validation, as it can help in differentiating severe asthma with fungal sensitization from ABPA-S. Minor criteria have been ...

Introduction Current bronchiectasis guidelines advise against the use of inhaled corticosteroids (ICS) except in patients with associated asthma, allergic bronchopulmonary aspergillosis (ABPA) and/or ...

0 Asymptomatic Never diagnosed to have ABPA in the past, presentation with controlled asthma (according to GINA guidelines) and meeting the diagnostic criteria of ABPA (Box 6) 1 Acute Never ...

The patient underwent a skin prick test and an allergen-specific IgE test for Aspergillus fumigatus, and both were positive. His bronchoalveolar lavage cultures also grew A. fumigatus, and he ...

BOSTON — Symptoms improved with mepolizumab after treatment with omalizumab failed for a patient with asthma who developed allergic bronchopulmonary aspergillosis, according to a poster ...